Key Takeaways
- The FDA will not use its Elsa AI platform to make decisions on drug approvals, Tala Fakhouri told the DIA Global Annual Meeting.
The US Food and Drug Administration is not using its Elsa generative artificial intelligence tool for regulatory decisions, associate director...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?